| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |